Dr. Michelle Sholzberg has advice what (and what not) to ask patients to get an accurate picture of whether their menstrual bleeding is really abnormal.
The new drug Litfulo (ritlecitinib) has reached the Canadian market, while baricitinib (Olumiant) is now approved for alopecia areata and in a new higher-strength tablet.
National guidelines recommend against screening until age 50, but Black, Hispanic and Asian women have peak incidence of breast cancer in their 40s, said Dr. Neil Isaac.
Canadian researchers say some women with early-stage cervical cancer can be safely treated with a less invasive hysterectomy that has fewer complications.
Denmark study finds no increased risk of 28 adverse events following vaccination with a monovalent XBB.1.5-containing vaccine given as a fifth dose to adults 65 years or older.
